Unknown

Dataset Information

0

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma.

ABSTRACT: The multiple myeloma treatment landscape has changed dramatically. This change, paralleled by an increase in scientific knowledge, has resulted in significant improvement in survival. However, heterogeneity remains in clinical outcomes, with a proportion of patients not benefiting from current approaches and continuing to have a poor prognosis. A significant proportion of the variability in outcome can be predicted on the basis of clinical and biochemical parameters and tumor-acquired genetic variants, allowing for risk stratification and a more personalized approach to therapy. This article discusses the principles that can enable the rational and effective development of therapeutic approaches for high-risk multiple myeloma.

SUBMITTER: Davies FE 

PROVIDER: S-EPMC9894570 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The multiple myeloma treatment landscape has changed dramatically. This change, paralleled by an increase in scientific knowledge, has resulted in significant improvement in survival. However, heterogeneity remains in clinical outcomes, with a proportion of patients not benefiting from current approaches and continuing to have a poor prognosis. A significant proportion of the variability in outcome can be predicted on the basis of clinical and biochemical parameters and tumor-acquired genetic va  ...[more]

Similar Datasets

Unknown Risk and Response-Adapted Treatment in Multiple Myeloma.
| S-EPMC7760158 | biostudies-literature
Unknown Risk Stratification and Treatment in Smoldering Multiple Myeloma.
| S-EPMC8750018 | biostudies-literature
Unknown Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives.
| S-EPMC4777772 | biostudies-literature
Unknown Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives.
| S-EPMC10145990 | biostudies-literature
Unknown Perspectives for the Use of CAR-T Cells for the Treatment of Multiple Myeloma.
| S-EPMC7943463 | biostudies-literature
Unknown Consolidation in multiple myeloma - current status and perspectives.
| S-EPMC4248062 | biostudies-literature
Unknown Treatment of multiple myeloma.
| S-EPMC3773461 | biostudies-literature
Unknown Current diagnosis, risk stratification and treatment paradigms in newly diagnosed multiple myeloma.
| S-EPMC8688330 | biostudies-literature
Unknown Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma.
| S-EPMC2700334 | biostudies-literature
Unknown Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives.
| S-EPMC9266328 | biostudies-literature